US FDA allows warnings on OTC benzocaine

13 May 2014 - Deborah Wilkes


The US Food and Drug Administration (FDA) has told manufacturers of OTC oral healthcare products containing benzocaine that product labelling can include a warning about methemoglobinemia.

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: